Quimada, Baby Boy .

HRN: 29-18-46  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2026
AMPICILLIN 250MG (VIAL)
06/20/2026
06/27/2026
IV
180mg
Q12
PSNB
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  PneumoniaBloodstreamProphylaxis    Compliance to guidelines: